Emilia
Cercenado Mansilla
Publicacións nas que colabora con Emilia Cercenado Mansilla (18)
2024
-
Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain
Infection
-
In vitro activity of cefiderocolagainst European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations
Microbiology Spectrum, Vol. 12, Núm. 8
2022
-
Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing
International Journal of Antimicrobial Agents, Vol. 59, Núm. 1
-
Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)
Microbiology spectrum, Vol. 10, Núm. 5, pp. e0292722
-
In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3163-3172
2021
-
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales
Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 6, pp. 1498-1510
-
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS
The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 2, pp. 370-379
-
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis
Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1631-1637
2020
-
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187
-
WGS characterization of MDR Enterobacterales with different ceftolozane/tazobactam susceptibility profiles during the SUPERIOR surveillance study in Spain
JAC-Antimicrobial Resistance, Vol. 2, Núm. 4
2019
-
Activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: The SUPERIOR multicentre study
International Journal of Antimicrobial Agents, Vol. 53, Núm. 5, pp. 682-688
2017
-
Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436
2016
-
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Journal of Infection, Vol. 72, Núm. 2, pp. 152-160
2015
-
Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain
International Journal of Antimicrobial Agents, Vol. 46, Núm. 2, pp. 157-163
2014
-
Inhibitor-resistant TEM- And OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates
Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 7, pp. 3874-3881
2013
-
Epidemiological and clinical complexity of amoxicillin-clavulanate- resistant Escherichia coli
Journal of Clinical Microbiology, Vol. 51, Núm. 7, pp. 2414-2417
2012
-
Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate
Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 8, pp. 4540-4543
-
Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli
Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 7, pp. 3576-3581